Class II recall: Baxter Healthcare Corporation: Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1

Baxter Healthcare Corporation has issued a Class II recall for Daptomycin in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), supplied in 1000 mL single dose containers under NDC 0338-0718-12. The recall notice cites current Good Manufacturing Practice (CGMP) deviations as the reason for the action.

Most relevant for: Clinicians and pharmacy staff managing intravenous daptomycin therapy for patients receiving this specific Baxter product lot.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.